We are live on ! Find out more
NRC icon

NRC Health Common Stock

110 hedge funds and large institutions have $466M invested in NRC Health Common Stock in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 43 increasing their positions, 43 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

6% more capital invested

Capital invested by funds: $441M → $466M (+$25.1M)

1.54% more ownership

Funds ownership: 45.71%47.25% (+1.5%)

1% more funds holding

Funds holding: 109110 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 43

Holders
110
Holders Change
+1
Holders Change %
+0.92%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
43
Reduced
43
Closed
5
Calls
$7K
Puts
Net Calls
+$7K
Net Calls Change
+$7K

NRC Hedge Fund Activity: Q3 2022 in Review

110 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in NRC Health Common Stock (NRC) for Q3 2022, worth a combined $466M — up 5.7% from $441M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NRC positions and 5 closed out — a net gain of 1 holder — while 43 added to existing stakes and 43 trimmed.

The largest buyer was Atlanta Capital Management, adding an estimated $6.37M. The largest seller was Renaissance Technologies, cutting an estimated $1.28M.

  • 110 institutional investors held NRC Health Common Stock (NRC) as of Q3 2022, up from 109 in Q2 2022.
  • Funds reported $466M of NRC Health Common Stock stock for Q3 2022, up 5.7% quarter-over-quarter.
  • 6 funds opened new NRC Health Common Stock positions in Q3 2022 and 5 closed out, a net change of +1 holder.
  • The largest NRC Health Common Stock buyer in Q3 2022 was Atlanta Capital Management, an estimated $6.37M added.
  • The largest NRC Health Common Stock seller in Q3 2022 was Renaissance Technologies, an estimated $1.28M sold.

Based on aggregated 13F filings for Q3 2022.